Schedule‐dependent neuroprotection by pioglitazone in a novel model of α‐synucleinopathy in rats: Integrated behavioural and histological outcomes

Documenti analoghi

• Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF‐2α dependent transcription
  di: Patrick G. Schweickert, et al.
  Pubblicazione: (2025)
• Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin‐induced hearing loss
  di: Anna Pisani, et al.
  Pubblicazione: (2024)
• Vortioxetine reduces the development of pain‐related behaviour in a knee osteoarthritis model in rats: Involvement of nerve growth factor (NGF) down‐regulation
  di: Maja Tomić, et al.
  Pubblicazione: (2024)
• Preclinical pharmacokinetics of novel long‐acting tenofovir alafenamide/bictegravir solid injectable in rats
  Pubblicazione: (2024)
• Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity
  di: Takayuki Suzuki, et al.
  Pubblicazione: (2026)